Exposomic Contributions to ADRD Pathology and Resilience
National Institutes of Health · Department of Health and Human Services
At a glance
Exposomic Contributions to ADRD Pathology and Resilience is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of October 5, 2026; forecast dates can change. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Posted
- Mar 11, 2026
- Est. close date
- Oct 5, 2026
- Est. award date
- Jun 1, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- Not specified
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects that investigate how specific neural exposome factors contribute mechanistically to Alzheimer’s disease-related dementias (ADRD) pathology and resilience. For the purposes of this program, exposome factors of interest include, but are not limited to, environmental toxins, sleep and circadian rhythms, stress, and the real-world conditions that modulate them (e.g., light, noise, heat).
Applications will be expected to propose research on the synergistic action between multiple exposome factors, and the composite effects of mixtures of exposome factors on neural mechanisms relevant to ADRD. Applicants are encouraged to focus on mechanistic pathways (e.g., microbiome–brain interactions, neuroimmune signaling, epigenetic modifications) that link exposures to ADRD risk, progression, and resilience. Applicants are further encouraged to consider studies that cover the lifespan, including work that investigates critical or sensitive periods of exposure or factors that may lead to neurological health disparities. Applicants may propose mechanistic, translational, and/or human subjects research, drawing on clinical data, human samples, and observational or interventional studies. However, NIH-defined clinical trials will not be supported under this program.
Applications are not currently being solicited. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigative teams with expertise in exposomics and environmental neuroscience, community engagement, ADRD mechanisms, and non-medical factors that may lead to health disparities are encouraged to apply.
Assistance Listing
What is an ALN?Reported obligations under ALN 93.853
Historical data · not a predictionAgency contact (as published)
NINDS Office of Neural Exposome and Toxicology and NINDS Office of Global Health and Health Disparities
NINDSONETOX@ninds.nih.gov
Please contact via e-mail.
Quick answers
Is “Exposomic Contributions to ADRD Pathology and Resilience” open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around July 1, 2026. Forecast details and dates can change.
Who is eligible to apply for “Exposomic Contributions to ADRD Pathology and Resilience”?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How do I apply for “Exposomic Contributions to ADRD Pathology and Resilience”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-NS-26-031), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Small Business Translator: MedTech and Digital Health Technologies
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Oct 20, 2025 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jan 5, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Feb 6, 2026 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- $3.5M – $4M
- Est. close
- Feb 20, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Feb 25, 2026 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection – Network Sites and Coordinating Center (U01- CT Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Mar 18, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more